MCQ Book Questions

Q55474. Which of the following â-adrenoceptor blockers has the minimal hepatic biotransformation ?

Q55475. Which of the following β –adrenoceptor blockers is the drug of choice for treatment of essential tremors ?

Q55476. Which of the following â-adrenoceptor blockers is used as anti-glaucoma agent

Q55477. Concurrent use of atropine will interfere with the anti-glaucoma action of

Q55478. To reduce the muscarinic side effects of oral forms of cholinesterase inhibitors they should be administered

Q55479. Which of the following cholinesterase inhibitors is said to produce more severe muscarinic side effects

Q55480. Which of the following cholinesterase inhibitors is preferred in patients hypersensitive to the bromide ion ?

Q55481. Following is a synthetic analogue of atropine, used as an inhalational drug in asthma

Q55482. All the cholinomimetic alkaloids except one which is a choline ester

Q55483. Which one of the following β β β β β – blockers has reduced risk of bronchospasm ?

Q55484. Metoprolol is a cardioselective beta block- er (relatively selective beta1 – blocker)

Q55485. Phenylephrine is useful as

Q55486. d-Amphetamine is not used in

Q55487. Following is a tertiary amine anti-mus- carinic drug used for Parkinson’s disease

Q55488. d-Amphetamine has most prominent

Q55489. Phenylephrine has most prominent

Q55490. Following is a tertiary amine anti-mus- carinic drug mainly used for mydriatic or cycloplegic action

Q55491. Relationship between arterial blood pressure (BP), cardiac outpur (CO) and peripheral vascular resistance (PVR) can be described as

Q55492. If a fibrinolytic drug is used for treatment of acute myocardial infarction, the adverse drug effect that is most likely to occur is

Q55493. Increased serum levels of which of the following may be associated with a decreased risk of atherosclerosis?